CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-12 | Zhang Yan CFO | Sale | −104 | $0.04 | $4 | 0 |
| 2023-12-21 | Kamdar Kim P. Director | Sale | −10 | $0.62 | $6 | 0 |
| 2022-12-31 | PELLETIER SAUNDRA L Chief Executive Officer | Returned to the company | −50,000 | 186,722 | ||
| 2022-05-27 | PELLETIER SAUNDRA L Chief Executive Officer | Purchase | +141,000 | $0.35 | $50K | 236,722 |
| 2022-05-04 | O'Brien Anthony Stephen Director | Grant or award · Stock option (right to buy) | +6,000 | 6,000 | ||
| 2022-05-04 | Kamdar Kim P. Director | Grant or award · Stock option (right to buy) | +6,000 | 6,000 | ||
| 2022-05-04 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +6,000 | 6,000 | ||
| 2022-05-04 | Rarick Lisa Dale Director | Grant or award · Stock option (right to buy) | +6,000 | 6,000 | ||
| 2022-05-04 | Greer Gillian Director | Grant or award · Stock option (right to buy) | +6,000 | 6,000 | ||
| 2022-02-18 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award | +300,000 | 516,422 | ||
| 2022-02-18 | Fitzpatrick Alexander A General Counsel and Secretary | Grant or award · Stock option (right to buy) | +300,000 | 300,000 | ||
| 2022-02-18 | File Justin J. Chief Financial Officer | Grant or award | +450,000 | 810,982 | ||
| 2022-02-18 | File Justin J. Chief Financial Officer | Grant or award · Stock option (right to buy) | +450,000 | 450,000 | ||
| 2022-02-18 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award | +750,000 | 1,435,837 | ||
| 2022-02-18 | PELLETIER SAUNDRA L Chief Executive Officer | Grant or award · Stock option (right to buy) | +750,000 | 750,000 | ||
| 2021-12-31 | Fitzpatrick Alexander A General Counsel and Secretary | Returned to the company | −120,000 | 216,422 | ||
| 2021-12-31 | File Justin J. Chief Financial Officer | Returned to the company | −120,000 | 360,982 | ||
| 2021-12-31 | PELLETIER SAUNDRA L Chief Executive Officer | Returned to the company | −300,000 | 685,837 | ||
| 2021-12-20 | Fitzpatrick Alexander A General Counsel and Secretary | Purchase | +25,000 | $0.39 | $10K | 336,422 |
| 2021-12-20 | File Justin J. Chief Financial Officer | Purchase | +40,594 | $0.37 | $15K | 480,982 |
Page 1 of 20 · 383 trades